Erythroid Neoplasm — Trials

Erythroid Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

260 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 48
Recruiting: 25
Ph III recruiting: 7
Growth YoY: —
Industry share: 48%
Top sponsor: National Cancer Institute (NCI)
Termination share: 35.9%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (50)

clinicaltrialsPublishedShowing 1–3 of 3 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06361641	Functional and Phenotypic Characterization of Monocytes in Myeloproliferative Syndromes(PHEMOP)	recruiting	N/A	70	University Hospital, AngersOTHER_GOV	1	Aug 10, 2026	clinicaltrials
NCT07445893	A Clinical Study of Gecacitinib Combined With Pegylated Interferon in Patients With PV	recruiting	N/A	30	Duan MinghuiOTHER	1	Jun 24, 2026	clinicaltrials